2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Kissling, EstherValenciano, Marta
Pozo, Francisco
Vilcu, Ana-Maria
Reuss, Annicka
Rizzo, Caterina
Larrauri, Amparo
Horváth, Judit Krisztina
Brytting, Mia
Domegan, Lisa
Korczyńska, Monika
Meijer, Adam
Machado, Ausenda
Ivanciuc, Alina
Višekruna Vučina, Vesna
van der Werf, Sylvie
Schweiger, Brunhilde
Bella, Antonino
Gherasim, Alin
Ferenczi, Annamária
Zakikhany, Katherina
O Donnell, Joan
Paradowska-Stankiewicz, Iwona
Dijkstra, Frederika
Guiomar, Raquel
Lazar, Mihaela
Kurečić Filipović, Sanja
Johansen, Kari
Moren, Alain
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
2015/16 I-MOVE/I-MOVE+ multicentre case-control study in Europe: Moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage-mismatched influenza B among children.Published in
Influenza Other Respir viruses 2018; 12(4):423-37Publiekssamenvatting
During the 2015/16 influenza season in Europe, the cocirculating influenza viruses were A(H1N1)pdm09 and B/Victoria, which was antigenically distinct from the B/Yamagata component in the trivalent influenza vaccine.PMID
29125681ae974a485f413a2113503eed53cd6c53
10.1111/irv.12520
Scopus Count
Collections
Except where otherwise noted, this item's license is described as Archived with thanks to Influenza and other respiratory viruses